Brief: Inozyme Pharma Announces Positive Interim Data From Phase 1 Seaport 1 Trial Of Inz-701

Inozyme Pharma

24/10/2024 18:16

Oct 24 (Reuters) - Inozyme Pharma Inc  INZY.O :
    * INOZYME PHARMA ANNOUNCES POSITIVE INTERIM DATA FROM PHASE
1
SEAPORT 1 TRIAL OF INZ-701
    * INOZYME PHARMA INC - INZ-701 INCREASES PPI LEVELS IN ESKD
PATIENTS UNDERGOING HEMODIALYSIS
    * INOZYME PHARMA INC - PLANS TO INITIATE REGISTRATIONAL
TRIAL IN
CALCIPHYLAXIS IN 2025
    * INOZYME PHARMA INC - INZ-701 SHOWS FAVORABLE SAFETY
PROFILE IN
PHASE 1 TRIAL

Further company coverage:  INZY.O 

 ((Reuters.Briefs@thomsonreuters.com;))